Last reviewed · How we verify

Amlodipine, losartan potassium and hydrochlorothiazide

Shanghai WiseGain Medical Devices Co., Ltd. · Phase 3 active Small molecule

Amlodipine, losartan potassium and hydrochlorothiazide is a Antihypertensive combination (calcium channel blocker + angiotensin II receptor blocker + thiazide diuretic) Small molecule drug developed by Shanghai WiseGain Medical Devices Co., Ltd.. It is currently in Phase 3 development for Hypertension (essential hypertension management).

This triple-combination antihypertensive reduces blood pressure through three complementary mechanisms: calcium channel blockade, angiotensin II receptor antagonism, and thiazide diuresis.

This triple-combination antihypertensive reduces blood pressure through three complementary mechanisms: calcium channel blockade, angiotensin II receptor antagonism, and thiazide diuresis. Used for Hypertension (essential hypertension management).

At a glance

Generic nameAmlodipine, losartan potassium and hydrochlorothiazide
SponsorShanghai WiseGain Medical Devices Co., Ltd.
Drug classAntihypertensive combination (calcium channel blocker + angiotensin II receptor blocker + thiazide diuretic)
TargetL-type calcium channels, AT1 angiotensin II receptor, sodium-chloride cotransporter
ModalitySmall molecule
Therapeutic areaCardiovascular
PhasePhase 3

Mechanism of action

Amlodipine blocks L-type calcium channels in vascular smooth muscle to cause vasodilation. Losartan potassium blocks angiotensin II type 1 receptors, preventing vasoconstriction and aldosterone release. Hydrochlorothiazide is a thiazide diuretic that reduces blood volume and sodium reabsorption. Together, these agents provide synergistic blood pressure reduction through distinct pathways.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Amlodipine, losartan potassium and hydrochlorothiazide

What is Amlodipine, losartan potassium and hydrochlorothiazide?

Amlodipine, losartan potassium and hydrochlorothiazide is a Antihypertensive combination (calcium channel blocker + angiotensin II receptor blocker + thiazide diuretic) drug developed by Shanghai WiseGain Medical Devices Co., Ltd., indicated for Hypertension (essential hypertension management).

How does Amlodipine, losartan potassium and hydrochlorothiazide work?

This triple-combination antihypertensive reduces blood pressure through three complementary mechanisms: calcium channel blockade, angiotensin II receptor antagonism, and thiazide diuresis.

What is Amlodipine, losartan potassium and hydrochlorothiazide used for?

Amlodipine, losartan potassium and hydrochlorothiazide is indicated for Hypertension (essential hypertension management).

Who makes Amlodipine, losartan potassium and hydrochlorothiazide?

Amlodipine, losartan potassium and hydrochlorothiazide is developed by Shanghai WiseGain Medical Devices Co., Ltd. (see full Shanghai WiseGain Medical Devices Co., Ltd. pipeline at /company/shanghai-wisegain-medical-devices-co-ltd).

What drug class is Amlodipine, losartan potassium and hydrochlorothiazide in?

Amlodipine, losartan potassium and hydrochlorothiazide belongs to the Antihypertensive combination (calcium channel blocker + angiotensin II receptor blocker + thiazide diuretic) class. See all Antihypertensive combination (calcium channel blocker + angiotensin II receptor blocker + thiazide diuretic) drugs at /class/antihypertensive-combination-calcium-channel-blocker-angiotensin-ii-receptor-blocker-thiazide-diuretic.

What development phase is Amlodipine, losartan potassium and hydrochlorothiazide in?

Amlodipine, losartan potassium and hydrochlorothiazide is in Phase 3.

What are the side effects of Amlodipine, losartan potassium and hydrochlorothiazide?

Common side effects of Amlodipine, losartan potassium and hydrochlorothiazide include Peripheral edema, Dizziness, Fatigue, Headache, Hyperuricemia, Hypokalemia.

What does Amlodipine, losartan potassium and hydrochlorothiazide target?

Amlodipine, losartan potassium and hydrochlorothiazide targets L-type calcium channels, AT1 angiotensin II receptor, sodium-chloride cotransporter and is a Antihypertensive combination (calcium channel blocker + angiotensin II receptor blocker + thiazide diuretic).

Related